Prasad R N, Koh S, Ratnam S S
Department of Obstetrics and Gynaecology, National University of Singapore, National University Hospital.
Contraception. 1989 Apr;39(4):369-83. doi: 10.1016/0010-7824(89)90116-9.
The results of a prospective longitudinal controlled study comparing the coagulation effects of a standard low-dose combined oral contraceptive (Microgynon 30), a desogestrel-containing pill (Marvelon) and a triphasic preparation (Triquilar) after one year's treatment in ethnic Chinese women is presented in this paper. In general the changes in coagulation parameters are similar to those seen in Caucasian women. The rise in Factor VII levels seen at 6 and 12 months in Marvelon users was not present to a significant degree in the other pill users. Antithrombin III levels remained unchanged in Microgynon and Marvelon users but with Triquilar there was a significant fall at 6 and 12 months of use. Whether these differences have any clinical relevance in the local Chinese population with low incidence of thromboembolism remains to be seen.
本文展示了一项前瞻性纵向对照研究的结果,该研究比较了标准低剂量复方口服避孕药(妈富隆30)、含去氧孕烯的药丸(美欣乐)和三相制剂(特居乐)在华裔女性中治疗一年后的凝血效果。总体而言,凝血参数的变化与白种女性相似。美欣乐使用者在6个月和12个月时出现的因子VII水平升高,在其他药丸使用者中未达到显著程度。妈富隆和美欣乐使用者的抗凝血酶III水平保持不变,但使用特居乐的使用者在使用6个月和12个月时出现了显著下降。这些差异在血栓栓塞发生率较低的当地华裔人群中是否具有任何临床相关性仍有待观察。